<VariationArchive VariationID="1733091" VariationName="NM_001114753.3(ENG):c.360+2dup" VariationType="Duplication" Accession="VCV001733091" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2022-11-29" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1796165" VariationID="1733091">
      <GeneList>
        <Gene Symbol="ENG" FullName="endoglin" GeneID="2022" HGNC_ID="HGNC:3349" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127815016" stop="127854658" display_start="127815016" display_stop="127854658" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130577290" stop="130617046" display_start="130577290" display_stop="130617046" Strand="-" />
          </Location>
          <OMIM>131195</OMIM>
          <Haploinsufficiency last_evaluated="2024-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ENG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2024-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ENG">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_001114753.3(ENG):c.360+2dup</Name>
      <CanonicalSPDI>NC_000009.12:127829684:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q34.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127829684" stop="127829685" display_start="127829684" display_stop="127829685" variantLength="1" positionVCF="127829684" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130591963" stop="130591964" display_start="130591963" display_stop="130591964" variantLength="1" positionVCF="130591963" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.130591964dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.130591964dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.127829685dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.127829685dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009551.1" sequenceAccession="NG_009551" sequenceVersion="1" change="g.30084dup">
            <Expression>NG_009551.1:g.30084dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114753.3" sequenceAccession="NM_001114753" sequenceVersion="3" change="c.360+2dup" MANESelect="true">
            <Expression>NM_001114753.3:c.360+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000118.4" sequenceAccession="NM_000118" sequenceVersion="4" change="c.360+2dup">
            <Expression>NM_000118.4:c.360+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278138.2" sequenceAccession="NM_001278138" sequenceVersion="2" change="c.-187+2dup">
            <Expression>NM_001278138.2:c.-187+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406715.1" sequenceAccession="NM_001406715" sequenceVersion="1" change="c.360+2dup">
            <Expression>NM_001406715.1:c.360+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_589" sequenceAccession="LRG_589">
            <Expression>LRG_589:g.30084dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001114753.3(ENG):c.360+2dup AND Cardiovascular phenotype" Accession="RCV002455204" Version="2">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001114753.3(ENG):c.360+2dup AND Hereditary hemorrhagic telangiectasia" Accession="RCV003099610" Version="2">
        <ClassifiedConditionList TraitSetID="43931">
          <ClassifiedCondition DB="MedGen" ID="C0039445">Hereditary hemorrhagic telangiectasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-13" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-16" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-11-29" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">17576681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22991266</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536098</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="43931" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="40362" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary hemorrhagic telangiectasia</ElementValue>
                <XRef ID="MONDO:0019180" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler hemorrhagic telangiectasia syndrome</ElementValue>
                <XRef ID="Osler+hemorrhagic+telangiectasia+syndrome/9046" DB="Genetic Alliance" />
                <XRef ID="21877004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler Weber Rendu syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ORW disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler-Rendu-Weber disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HHT</ElementValue>
                <XRef ID="GTR000525320" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="187300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000500010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515719" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6626" />
                <XRef ID="6626" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="774" DB="Orphanet" />
              <XRef ID="C0039445" DB="MedGen" />
              <XRef ID="MONDO:0019180" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS187300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6129496" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4882606|MedGen:C0039445" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003441461" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17576681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9536098</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22991266</ID>
          </Citation>
          <Comment>Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been observed in individuals with hereditary hemorrhagic telangiectasia (PMID: 22991266; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 3 of the ENG gene. It does not directly change the encoded amino acid sequence of the ENG protein. It affects a nucleotide within the consensus splice site.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.130591963_130591964insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0039445" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5103123" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a132377|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002615379" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22991266</ID>
          </Citation>
          <Comment>The c.360+2dupT intronic pathogenic mutation, results from a duplication of two nucleotides at nucleotide position 360 after intron 3 of the ENG gene. This variant, reported as c.360+3dupT, was identified in a family with a brain arteriovenous malformation; however, additional clinical information was not provided (Nishida T et al. Am. J. Med. Genet. A, 2012 Nov;158A:2829-34). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In silico splice site analysis predicts that this alteration will weaken the native splice donor site, and RNA studies have demonstrated that this alteration results in abnormal splicing in the set of samples tested (Ambry internal data). Other alterations impacting the same donor splice site (e.g., c.360+1G&gt;A, c.360+1G&gt;T, c.360+5G&gt;A, and c.360+5G&gt;C) have been reported in multiple individuals and families with hereditary hemorrahagic telangiectasia (HHT), and one (c.360+1G&gt;A) has been shown to have a similar impact on splicing (Pece N et al. J. Clin. Invest., 1997 Nov;100:2568-79; Berg J, J. Med. Genet. 2003 Aug; 40(8):585-9; Letteboer TG et al. Hum. Genet., 2005 Jan;116:8-16; Gedge F et al. J Mol Diagn, 2007 Apr;9:258-65). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001114753.1:c.360+2dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6129496" TraitType="Disease" MappingType="XRef" MappingValue="C0039445" MappingRef="MedGen">
        <MedGen CUI="C0039445" Name="Hereditary hemorrhagic telangiectasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5103123" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

